Synergistic Membrane Disturbance Improves the Antibacterial Performance of Polymyxin B

Drug-resistant Gram-negative bacteria pose a serious threat to public health, and polymyxin B (PMB) is clinically used as a last-line therapy for the treatment of infections caused by these pathogens. However, the appearance of PMB resistance calls for an effort to develop new approaches to improve...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wenwen, Zhang, Che, Lu, Xuemei, Sun, Shuqing, Yang, Kai, Yuan, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611124/
https://www.ncbi.nlm.nih.gov/pubmed/36297894
http://dx.doi.org/10.3390/polym14204316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611124/
https://www.ncbi.nlm.nih.gov/pubmed/36297894
http://dx.doi.org/10.3390/polym14204316

Ejemplares similares